Penicillin is still the antibiotic of choice in the therapy of gonorrhoea, but the administration of this antibiotic may be limited by various factors. Anaphylactic shock may occur and may even be fatal (Rosenthal, 1958; Fazekas and Veress, 1964; Schummelfeder, Klein, and Stuttgen, 1965) .
A higher incidence of such complications is to be expected as a result of the gradual increase in the number of those with penicillin allergy (Luckerath, 1969; Maciejowska, 1969; Sonnichsen, Metzner, and Rietschel, 1969) . On the one hand detection of such persons is improved bymore sensitivetesting methods. On the other hand the general population is brought increasingly into contact with penicillin, either by penicillin-contaminated food or by infection with penicillin-producing dermatophytes (G6tz, 1962; Blum and de Weck, 1966) .
The increased number of gonococcal strains less sensitive to penicillin has been widely reported (Juhlin, 1965; Amies, 1967; Smith and Levey, 1967; Storck and Schwarz-Speck, 1969; Silver and Darling, 1971; Wols-van der Wielen, 1971 ). This has also been our experience in recent years, and is another reason why numerous other antibiotics and chemotherapeutic agents have been used to treat gonorrhoea. Hellgren (1969) thought that treating gonorrhoea with penicillin was no longer justified because the disease was not serious enough to warrant the risk of fatal anaphylaxis.
For these reasons, we have tried the relatively new antibiotic gentamicin, which has the additional advantage of leaving T. pallidum unaffected.
Methods
Smears and cultures were taken from the urethra in males and from the cervix, urethra, and sometimes the anal canal, in females. The methods of taking and staining the smears and of setting up the cultures have been reported in detail elsewhere (Hantschke, 1970 
FOLLOW-UP TESTS
Follow-up smears and cultures were taken on three, and in complicated infections, four occasions after treatment -the last between the 3rd and 10th day. The blood urea nitrogen and serum creatinine estimations were also repeated.
A further ENT examination was carried out in all cases on the 6th day after treatment and was repeated in many cases 4 weeks after treatment.
Serum levels
In five patients serum levels of gentamicin were estimated. Specimens were taken before therapy-as a control -and 30 min., 1 hr, 90 min., and 2, 4, 8, 12, and 24 hrs after the injection. The serum levels were determined by the well-diffusion method. To special plates containing 100 ml. DST-agar (Oxoid), 1 ml. sporular suspension (Bacillus subtilis ATCC 6633; germ count 15 million per ml.) was added. Into a well of 9 mm. diameter was placed 0-1 ml. of the pertinent serum dilution. The pre-treatment specimen of serum and a phosphate buffer standard served as controls. Pre-diffusion at room temperature for 2 hrs was followed by aerobic cultivation for 20 to 24 hrs. The results thus yielded were related to the phosphate buffer standard.
Results
Altogether 62 patients with gonococcal infection (48 females and 14 males) were treated. Two women had salpingitis, and one man epididymitis. Cure was obtained in 58 cases (94 per cent.), but gonorrhoea recurred in three women and one man.
Treatment of gonorrhoea with gentamicin 63
Peak serum levels were reached 30 minutes after the injection, and usually started to fall after 2 hours. After 12 hours the level was hardly measurable (Figure) . The levels obtained are well above the minimum inhibitory concentrations (MICs) of the strains of gonococci which we have tested. (1) The MICs yielded by 158 strains of gonococci tested by the serial dilution test described by Hantschke (1970) . With fourteen strains the MIC was 0 09 ag./ml. and with five strains 6-25 [±g./ml.; the remaining strains showed intermediate values.
(2) The findings of other workers (Polemann and Eichler, 1967; Hantschke and Mauss, 1970; Felarca, Laqui, and Ibarra, 1970; Mirarchi and Plante, 1971) . The last named used almost the same dosage as we did, whereas Felarca and others (1970) gave up to 6 mg. gentamicin per kg. body weight. None of these authors observed any side-effects. The aminoglycoside antibiotics are known to cause vestibular and auditory damage. Such effects have been reported from the use of kanamycin (J0rgensen and Schmidt, 1962) , neomycin (Wagemann, 1960) , and also gentamicin (Pirsig and Rollin, 1969; Witzel, 1970; Federspil, 1971) . A common denominator could be established with the majority of the patients so affected, namely a marked renal insufficiency.
From the experimental work of Voldfich (1965) and Stupp, Rauch, Sous, and Lagler (1966) , the possibility-of ototoxicity may be deduced as follows: when an aminoglycoside antibiotic is injected, high serum levels are promptly obtained with a half-life of 30 to 90 minutes. The antibiotic level in the perilymph of the inner ear does not rise at the same rate but excretion from this site is retarded. When therapy with an aminoglycoside antibiotic is continued for some time, even with relatively low doses, an accumulation may occur in the inner ear fluid, particularly in the presence of renal insufficiency. When a single high dose is given there may be a marked rise in the aminoglycoside antibiotic level in the perilymph of the inner ear. Stupp (1970) demonstrated this experimentally with kanamycin in the guinea-pig. If saturation of the perilymph occurs after either method of administration and is maintained over a given period (as yet unknown) toxic damage of the sensory cells probably occurs. None of our patients treated with gentamicin showed evidence of ototoxicity and those with slightly impaired hearing before treatment showed no deterioration on follow-up, but the serum levels obtained in our patients might not be safe in patients with renal insufficiency or in a poor general state of health.
Holzmann, Tupath-Barniske, and Morsches (1969) showed, in a serial dilution test, that concentrations of gentamicin of 0.0005 to 500 ,ug./ml. nutrient broth had no effect on Treponema pallidum. These observations are in contrast to those of Heitmann and Bill (1971) , but are supported by the recent large-scale investigations of Petzoldt (1972 Gentamicin was supplied as 'Sulmycin' ampoules by Byk-Essex, Munich, Germany.
